-
Mashup Score: 1Take the Risk Test Today - 2 year(s) ago
Learn your risk for type 2 diabetes in one minute.
Source: donations.diabetes.orgCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 4
It has been 100 years since the discovery of #insulin. We’ve come a long way since 1921 and we know there’s more work to be done! Tune in NOW!
Source: YouTubeCategories: Endocrinology, Latest HeadlinesTweet-
As we continue to learn about diabetes, let's not forget that this year marks 100 years since the discovery of #insulin. Listen in on this #ADA2021 session about insulins past, present, and future: https://t.co/a6TnfK8Les #ADM2021 #TheBigStepUp
-
-
Mashup Score: 9Testosterone Therapy for Hypogonadism With Diabetes? - 3 year(s) ago
Nonrandomized 12-year data do not provide hard conclusions about testosterone benefit vs risk for men with low T and diabetes; one RCT has been published, but the jury is still out on safety.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
A study of men with T2D and low testosterone suggests that patients who receive up to 12 years of testosterone injections every 3 months may improve glycemic control. https://t.co/r3W29MfTcC #ADA2021
-
-
Mashup Score: 2New FDA Guidance on T2D Trial Design Provides Flexibility - 3 year(s) ago
The FDA released new draft guidance for the evaluation of type 2 diabetes drugs. Dr John Buse discusses the impact this could have on clinical trials and the medications we might see from the changes.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The 2020 draft guidance from the FDA surrounding #cardiovascular trials in people with diabetes provides a lot more flexibility now. https://t.co/qJ1rCKKab1 #ADA2021 https://t.co/zGvA2CiTmX
-
-
Mashup Score: 6New FDA Guidance on T2D Trial Design Provides Flexibility - 3 year(s) ago
The FDA released new draft guidance for the evaluation of type 2 diabetes drugs. Dr John Buse discusses the impact this could have on clinical trials and the medications we might see from the changes.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
The 2020 draft guidance from the FDA surrounding cardiovascular trials in people with diabetes provides a lot more flexibility now. https://t.co/7RM7VPO8DL #ADA2021 https://t.co/146sX3bQMp
-
-
Mashup Score: 4New Agents for Youth-Onset Type 2 Diabetes 'Finally in Sight' - 3 year(s) ago
‘A number of clinical trials of antidiabetic pharmacologic agents in diabetic youth have been completed, demonstrating safety and efficacy, and a wider availability of agents is finally in sight,’ said an expert.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
New clinical trials of antidiabetic pharmacologic agents are bringing options to younger diabetes patients. https://t.co/9f877xVTM4 #ADA2021
-
-
Mashup Score: 1With Tirzepatide, a 'Great Future' for Patients With T2D - 3 year(s) ago
Dr Juan Frias discusses results from the SURPASS trials and how tirzepatide might eventually be used in the clinical setting.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Discussion on the positive future forecasted for this glucose-lowering combination therapy after completing five pivotal clinical trials in T2D. https://t.co/QEhAhdj67P #ADA2021 https://t.co/PDk2Fvsjsx
-
-
Mashup Score: 0New agents for youth-onset type 2 diabetes ‘finally in sight’ - 3 year(s) ago
‘A number of clinical trials of antidiabetic pharmacologic agents in diabetic youth have been completed, demonstrating safety and efficacy, and a wider availability of agents is finally in sight,’ said an expert.
Source: www.mdedge.comCategories: Latest Headlines, PediatricsTweet-
There are limited treatment options for children and youth with #T2D, but a few novel therapies beyond metformin are on the horizon, say experts. https://t.co/L2M4XIUM3I #ADA2021 https://t.co/YH1ki1ZTdN
-
-
Mashup Score: 4Not So Crazy: Pancreas Transplants in Type 2 Diabetes Rising - 3 year(s) ago
Simultaneous pancreas-kidney transplants are increasingly performed in patients with type 2 diabetes and chronic kidney disease, who now account for about 20% of all pancreas transplants in the US.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Roughly 50%-60% of candidates on the kidney transplant waiting list also have T2D so the fact that simultaneous pancreas-kidney transplants are increasingly performed, isn’t such a crazy idea anymore. https://t.co/qroRV1Lt5V #ADA2021
-
-
Mashup Score: 0New Agents for Youth-Onset Type 2 Diabetes 'Finally in Sight' - 3 year(s) ago
‘A number of clinical trials of antidiabetic pharmacologic agents in diabetic youth have been completed, demonstrating safety and efficacy, and a wider availability of agents is finally in sight,’ said an expert.
Source: MedscapeCategories: Latest Headlines, PediatricsTweet-
Youth with T2D have limited treatment options besides taking #metformin, but new clinical trials of antidiabetic pharmacologic agents are bringing options. https://t.co/pSYd1CpmAg #ADA2021
-
Risk test time! Visit https://t.co/9NoRAUdjMH and take the risk test. Take a selfie when you're done and tag us & 3-5 friends encouraging them to do the same! #ADA2021 #TheBigStepUp https://t.co/xx6MjLN2cN